medigraphic.com
ISSN 2078-7170 (Electronic)

2016, Number 1

<< Back Next >>

CorSalud 2016; 8 (1)

Characterization of atrial fibrillation in the Department of Internal Medicine at “Hospital Nacional San Rafael” (El Salvador)

Merino BSI, Mercedes JM, Landaverde HJR, Lazo MSC, Morán QJA, Moreno-Martínez FL, Bello QME, Flores MJJ, González FV, González CB

Language: Spanish
References: 40
Page: 8-18
PDF size: 445.95 Kb.


ABSTRACT

Introduction: Atrial fibrillation is a serious health problem. Central American countries are not exempt from this scourge.
Objective: To characterize atrial fibrillation, specify its clinical and epidemiological variables and determine stroke risks by using CHA2DS2-VASc score.
Method: A descriptive and prospective study was carried out on 107 patients admitted with diagnosis of atrial fibrillation, in the Department of Internal Medicine at “Hospital Nacional San Rafael” from Santa Tecla city, La Libertad, El Salvador, from January to July 2013. The clinical and epidemiological variables were analyzed, an echocardiogram was performed on all patients and CHA2DS2-VASc risk score was calculated. Methods were used to establish the relationships between variables.
Results: More than half of atrial fibrillation patients (57.0%; p=0.015) are women, 51.4% white and the average age is 74.7 ± 13.8 years. 80.4% of patients have nonvalvular atrial fibrillation. There was hypertension prevalence (54.2%), ischemic heart disease (28.0%), hypertensive (23.4%) and dilated cardiomyopathies (24.3%), and permanent atrial fibrillation (49.5%). The left atrium average size was 42.67 ± 8.2 mm. The lower ejection fraction (p=0.012) and increased left ventricular diastolic diameter (p=0.004) showed significant relationship with the occurrence of non-valvular atrial fibrillation. 84.9% of patients have a high risk of stroke according to CHA2DS2-VASc score. Age older than 75 years (p ‹ 0.001), between 65 and 74 (p=0.025), female sex (p=0.001) and increased thickness of the interventricular septum (p=0.006) were associated with higher risk.
Conclusions: The lower ejection fraction and increased left ventricular diastolic diameter were associated with atrial fibrillation. Most patients have a high risk of stroke; variables associated are older age, female gender and increased thickness of the interventricular septum.


REFERENCES

  1. Organización Mundial de la Salud. Oficina Regional para las Américas / Organización Panamericana de la Salud. OMS 2016 [citado 21 Mar 2015]. Disponible en: http://www.who.int/about/regions/amro/es/

  2. Camm AJ, Kirchhof P, Lip GY, Schotten U, Savelieva I, Ernst S, et al. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J. 2010;31: 2369-429.

  3. Cea-Calvo L, Redón J, Lozano JV, Fernández-Pé- rez C, Martí-Canales JC, Llisterri J L, et al. Prevalencia de fibrilación auricular en la población española de 60 o más años de edad. Estudio PREV-ICTUS. Rev Esp Cardiol. 2007;60:616-24.

  4. Stewart S, Hart CL, Hole DJ, McMurray JJ. Population prevalence, incidence, and predictors of atrial fibrillation in the Renfrew/Paisley study. Heart. 2001;86:516-21.

  5. Zimerman LI, Fenelon G, Filho MM, Grupi C, Atié J, Lorga Filho A, et al. Diretrizes brasileiras de Fibrilação Atrial. Arq Bras Cardiol. 2009;92(6 Supl. 1):1-39.

  6. Fuenmayor AJ, Fuenmayor AM. Tratamiento no farmacológico de la fibrilación auricular. Avances Cardiol. 2009;29:286-95.

  7. Inoue H, Fujiki A, Origasa H, Ogawa S, Okumura K, Kubota I, et al. Prevalence of atrial fibrillation in the general population of Japan: An analysis based on periodic health examination. Int J Cardiol. 2009;137:102-7.

  8. Miyasaka Y, Barnes ME, Gersh BJ, Cha SS, Bailey KR, Abhayaratna WP, et al. Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation. 2006; 114:119-25.

  9. Christensen MC, Valiente R, Sampaio Silva G, Lee WC, Dutcher S, Guimarães Rocha MS, et al. Acute treatment costs of stroke in Brazil. Neuroepidemiology. 2009;32:142-9.

  10. Christensen MC, Previgliano I, Capparelli FJ, Lerman D, Lee WC, Wainsztein NA, et al. Acute treatment costs of intracerebral hemorrhage and ischemic stroke in Argentina. Acta Neurol Scand. 2009;119:246-53.

  11. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke. 1991;22:983-8.

  12. Marini C, De Santis F, Sacco S, Russo T, Olivieri L, Totaro R, et al. Contribution of atrial fibrillation to incidence and outcome of ischemic stroke: results from a population-based study. Stroke. 2005; 36:1115-9.

  13. Nattel S, Burstein B, Dobrev D. Atrial remodeling and atrial fibrillation: mechanisms and implications. Circ Arrhythm Electrophysiol. 2008;1:62-73.

  14. Sato H, Ishikawa K, Kitabatake A, Ogawa S, Maruyama Y, Yokota Y, et al. Low-dose aspirin for prevention of stroke in low-risk patients with atrial fibrillation: Japan Atrial Fibrillation Stroke Trial. Stroke. 2006;37:447-51.

  15. Ogilvie IM, Welner SA, Cowell W, Lip GY. Ischaemic stroke and bleeding rates in ‘real-world’ atrial fibrillation patients. Thromb Haemost. 2011; 106:34-44.

  16. Friberg L, Benson L, Lip GY. Balancing stroke and bleeding risks in patients with atrial fibrillation and renal failure: the Swedish Atrial Fibrillation Cohort study. Eur Heart J. 2015;36:297-306.

  17. Lip GY. The role of aspirin for stroke prevention in atrial fibrillation. Nat Rev Cardiol. 2011;8:602-6.

  18. Mant J, Hobbs FD, Fletcher K, Roalfe A, Fitzmaurice D, Lip GY, et al. Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial. Lancet. 2007;370:493-503.

  19. Friberg L, Rosenqvist M, Lip GY. Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study. Eur Heart J. 2012;33:1500-10.

  20. Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro Heart Survey on Atrial Fibrillation. Chest. 2010;137:263-72.

  21. Olesen JB, Lip GY, Hansen ML, Hansen PR, Tolstrup JS, Lindhardsen J, et al. Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study. BMJ [Internet]. 2011 [citado 2 Ago 2015];342:d124. Disponible en: http://www.bmj.com/content/bmj/342/bmj.d124.f ull.pdf

  22. Boriani G, Botto GL, Padeletti L, Santini M, Capucci A, Gulizia M, et al. Improving stroke risk stratification using the CHADS2 and CHA2DS2- VASc risk scores in patients with paroxysmal atrial fibrillation by continuous arrhythmia burden monitoring. Stroke. 2011;42:1768-70.

  23. Cruz Cardentey M, Pérez Rivera T, Méndez Rosabal A. Factores predictores de éxito de la cardioversión eléctrica en la fibrilación auricular. CorSalud [Internet]. 2014 [citado 15 Ago 2015];6: 280-7. Disponible en: http://www.corsalud.sld.cu/sumario/2014/v6n4a1 4/cv-fa.html

  24. Chávez González E. Fibrilación auricular en el paciente hipertenso. Papel de la aurícula izquierda. CorSalud [Internet]. 2011 [citado 2 Ago 2015];3:50- 2. Disponible en: http://www.corsalud.sld.cu/sumario/2011/v3n1a1 1/fibrilacion.htm

  25. Knecht S, Oelschläger C, Duning T, Lohmann H, Albers J, Stehling C, et al. Atrial fibrillation in stroke-free patients is associated with memory impairment and hippocampal atrophy. Eur Heart J. 2008;29:2125-32.

  26. Yiu KH, Tse HF. Hypertension and cardiac arrhythmias: a review of the epidemiology, pathophysiology and clinical implications. J Hum Hypertens. 2008;22:380-8.

  27. Gómez Peña, Silva Velazco E, Diéguez Paz A, Parra Morales R. Comportamiento clínica de la fibrilación atrial en paciente admitidos al servicio de urgencia. Rev Cub Med Int Emerg [Internet]. 2008 [citado 2 Ago 2015];7. Disponible en: http://bvs.sld.cu/revistas/mie/vol7_1_08/mie0410 8.htm

  28. Del Corral Beamonte E, Fleta Asín B, Martínez Moya L, García Noain A, Gonzalvo Liarte MA. Hipertensión arterial, un antecedente frecuente en los pacientes con fibrilación auricular. Comunicaciones. 9ª Reunión Nacional SEH-LELHA [CDROM]. Murcia: Elsevier; 2004.

  29. Chávez González E, Carmona Puerta R. Riesgo de arritmias e hipertensión arterial. CorSalud [Internet]. 2012 [citado 15 Ago 2015];4:130-5. Disponible en: http://bvs.sld.cu/revistas/cors/pdf/2012/v4n2a12/ es/htaarritmias.pdf

  30. Moreno-Martínez FL, Groning González DV, Fleites Cárdenas HA, Lagomasino Hidalgo A, Gonzá- lez Alfonso O, Ramos Ramírez RR, et al. Reversión de fibrilación auricular paroxística con amiodarona después de una revascularización miocárdica quirúrgica sin bomba. Rev Fed Arg Cardiol. 2005;34:118-23.

  31. Chávez González E, Carmona Puerta R. Razones y método para prevenir la fibrilación auricular cuando puede lograrse. CorSalud [Internet]. 2012 [citado 15 Ago 2015];4:144-5. Disponible en: http://bvs.sld.cu/revistas/cors/pdf/2012/v4n2a12/ es/razones.pdf

  32. Pandit SV, Jalife J. Aging and atrial fibrillation research: where we are and where we should go. Heart Rhythm. 2007;4(2):186-7.

  33. European Heart Rhythm Association; Heart Rhythm Society, Fuster V, Rydén LE, Cannom DS, Crijns HJ, et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation. J Am Coll Cardiol. 2006;48:854-906.

  34. Rodríguez Rosales E, de Arazoza Hernández A, Vázquez Castro F, Moreno-Martínez FL. Factores de riesgo de fibrilación auricular posoperatoria en cirugía cardíaca. CorSalud [Internet]. 2014 [citado 2 Ago 2015];6:174-80. Disponible en: http://www.corsalud.sld.cu/sumario/2014/v6n2a1 4/fapo.html

  35. García-Acuña JM, González-Juanatey JR, Alegría Ezquerra E, González Maqueda I, Listerri JL. La fibrilación auricular permanente en las enfermedades cardiovasculares en España. Estudio CARDIOTENS 1999. Rev Esp Cardiol 2002; 55: 943- 952.

  36. Kannel WB, Wolf PA, Benjamin EJ, Levy D. Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. Am J Cardiol. 1998;82(8A):2N-9N.

  37. Sohaib SM, Fox KF. A meta-analysis of left atrial appendage closure for stroke prevention in atrial fibrillation-adding to the debate but elements remain unresolved. J Thorac Dis. 2015;7:E226-9.

  38. Zeus T, Kelm M, Bode C. Prophylaxis of thromboembolism in atrial fibrillation: new oral anticoagulants and left atrial appendage closure. Dtsch Med Wochenschr. 2015;140:1213-5.

  39. Chávez González E. Dispersión de la onda P. Predicción de fibrilación auricular en el paciente hipertenso. CorSalud [Internet]. 2010 [citado 2 Ago 2015];2:190-2. Disponible en: http://www.corsalud.sld.cu/sumario/2010/v2n3a1 0/dispersion.htm

  40. Bayes de Luna AJ. Las bases electrofisiológicas: de la electrofisiología celular al electrocardiograma humano. En: Bayes de Luna AJ, Bayes Genis A, Brugada R, eds. Electrocardiografía clínica. 7ma. Ed. Barcelona: Permanyer; 2012. p. 35-56.




2020     |     www.medigraphic.com